Hematopoietic growth factors and marrow stroma in aplastic anemia

International Journal of Hematology

Volumn 68, Issue 1, 1998, Pages 19-28

  Koijima, Seiji ^a  

^a Children's Medical Centre   (Japan)

Author keywords

Aplastic anemia; Hematopoietic growth factors; Marrow stroma

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL CELL; APLASTIC ANEMIA; BONE MARROW CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL MATURATION; CELL VIABILITY; GROWTH INHIBITION; HEMATOPOIESIS; LIGAND BINDING; MONOLAYER CULTURE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STROMA CELL;

EID: 0032125771     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00028-0     Document Type: Review

References (92)

1. Camitta B.M., Storb R., Thomas E.D. Aplastic anemia: pathogenesis, diagnosis, treatment and prognosis. New Engl J Med. 306:1982;645-650.
2. Young N.S., Maciejewski J. The pathophysiology of acquired aplastic anemia. New Engl J Med. 336:1997;1365-1372.
3. Frickhofen N., Kaltwasser J.P., Schrezenmeier H.et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. New Engl J Med. 324:1991;1297-1304.
4. Bacigalupo A., Chaple M., Hows J.et al. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party. Br J Haematol. 83:1993;145-151.
5. Rosenfeld S.J., Kimball J., Vining D., Young N.S. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 85:1995;3058-3065.
6. Tichelli A., Gratwohl A., Würsch A., Nissen C., Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol. 69:1988;413-418.
7. de Planque M., Bacigalupo A., Würsch A.et al. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). Br J Haematol. 73:1989;121-126.
8. Socié G., Henry A.M., Bacigalupo A.et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation - Severe Aplastic Anaemia Working Party. New Engl J Med. 329:1993;1152-1157.
9. Ohara A., Kojima S., Hamajima N.et al. Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood. 90:1997;1009-1013.
10. Dexter T.M., Allen T.D., Lajtha L.G. Conditions controlling the proliferation of hemopoietic stem cells in vitro. J Cell Physiol. 91:1977;335-344.
11. Gartner S., Kaplan H.S. Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA. 77:1980;4756-4759.
12. Shadduck R.K., Waheed A., Greenberger J.S., Dexter T.M. Production of colony stimulating factor in long-term bone marrow cultures. J Cell Physiol. 114:1983;88-92.
13. Kaushansky K., Lin N., Adamson J.W. Interleukin-1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. J Clin Invest. 81:1988;92-97.
14. Linenberger M.L., Jacobsen F.W., Bennett L.G., Broudy V.C., Martin F.H., Abkowitz J.L. Stem cell factor production by human marrow stromal fibroblasts. Exp Hematol. 23:1995;1104-1114.
15. Nissen C., Moser Y., Speck B., Gratwohl A., Weis J. Stimulatory serum factors in aplastic anaemia. Br J Haematol. 61:1985;499-512.
16. Yen Y.P., Zabala P., Doney K.et al. Haematopoietic growth factors in human serum. Erythroid burst-promoting activity in normal subjects and in patients with severe aplastic anaemia. J Lab Clin Med. 106:1985;384-392.
17. Kranz S.B. Erythropoietin. Blood. 77:1991;419-434.
18. Erslev A.J. Erythropoietin. New Engl J Med. 324:1991;1339-1344.
19. Erslev A.J., Caro J., Mileer O., Silver R. Plasma erythropoietin in health and disease. Ann Clin Lab Sci. 10:1980;250-257.
20. Urabe A., Mitani K., Yoshinaga K.et al. Serum erythropoietin titers in haematological malignancies and related diseases. Int J Cell Cloning. 10:1992;333-337.
21. Gaines Das R.E., Milne A., Rowley M., Gordon-Smith E.C., Cotes P.M. Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. Br J Haematol. 82:1992;601-607.
22. Schrezenmeier H., Noe G., Raghavachar A., Rich I.N., Heimpel H., Kubanek B. Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia. Br J Haematol. 88:1994;286-294.
23. Kojima S., Matsuyama T., Kodera Y. Circulating erythropoietin in patients with acquired aplastic anaemia. Acta Haematol. 94:1995;117-122.
24. Demetri G.D., Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood. 78:1991;2791-2808.
25. Lieschke G.J., Burgess A.W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. New Engl J Med. 327:1992;28-35.
26. Kojima S., Fukuda M., Miyajima Y., Matsuyama T., Horibe K. Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood. 77:1991;937-941.
27. Kojima S., Matsuyama T. Stimulation of granulopoiesis by high-dose recombinant human granulocyte colony-stimulating factor in children with aplastic anemia and very severe neutropenia. Blood. 83:1994;1474-1478.
28. Watari K., Asano S., Shirafuji N.et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood. 73:1989;117-122.
29. Motojima H., Kobayashi T., Shimane M., Kamachi S., Fukushima M. Quantitative enzyme immunoassay for human granulocyte colony stimulating factor (G-CSF). J Immunol Methods. 118:1989;187-192.
30. Omori F., Okamura S., Shimoda K., Otsuka T., Harada M., Niho Y. Levels of human serum granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditions. Biotherapy. 4:1992;147-153.
31. Kojima S., Matsuyama T., Kodera Y.et al. Measurement of endogenous plasma granulocyte colony-stimulating factor in patients with acquired aplastic anemia by a sensitive chemiluminescent immunoassay. Blood. 87:1996;1303-1308.
32. Kiriyama R., Chichibu K., Matsuno T., Ohsawa N. Sensitive chemiluminescent immunoassay for human granulocyte colony-stimulating factor (G-CSF) in clinical applications. Clin Chim Acta. 220:1993;201-209.
33. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood. 86:1995;419-431.
34. de Sauvage F.C., Hass P.E., Spencer S.D.et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 369:1994;533-538.
35. Lok S., Kaushansky K., Holley R.D.et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 369:1994;565-568.
36. Wendling F., Maraskovsky E., Debili N.et al. c-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 369:1994;571-574.
37. Bartley T.D., Bogenberger J., Hunt P.et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell. 77:1994;1117-1124.
38. Sohma Y., Akahori H., Seki N.et al. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett. 353:1994;57-61.
39. Emmons R.V.B., Reid D.M., Cohen R.L.et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood. 87:1996;4068-4071.
40. Marsh J.C.W., Gibson F.M., Prue R.L.et al. Serum thrombopoietin levels in patients with aplastic anaemia. Br J Haematol. 95:1996;605-610.
41. Kojima S., Matsuyama T., Kodera Y., Tahara T., Kato T. Measurement of endogenous plasma thrombopoietin in patients with acquired aplastic anaemia by a sensitive enzyme-linked immunosorbent assay. Br J Haematol. 97:1997;538-543.
42. Tahara T., Usuki K., Sato H.et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haematopoietic disorders. Br J Haematol. 93:1996;783-788.
43. Williams D.E., Elisenman J., Baird A.et al. Identification of a ligand for the c-kit proto-oncogene. Cell. 63:1990;167-174.
44. Zsebo K.M., Williams D.A., Geissler E.N.et al. Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell. 63:1990;213-224.
45. Huang E., Nocka K., Beier D.R.et al. The hematopoietic growth factor KL is encoded by the SI locus and it's the ligand of the c-kit receptor, the gene product of the W locus. Cell. 63:1990;225-233.
46. Martin F.H., Suggs S.V., Langley K.E.et al. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell. 63:1991;203-212.
47. Anderson D.M., Lyman S.D., Baird A.et al. Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell. 63:1990;235-243.
48. Tsuji K., Zsebo K.M., Ogawa M. Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit. Blood. 78:1991;1223-1229.
49. McNiece I.K., Langley K.E., Zsebo K.M. Recombinant human stem cell factor synergizes with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol. 19:1991;226-231.
50. Bagnara G.P., Strippoli P., Bonsi L.et al. Effect of stem cell factor on colony growth from acquired and constitutional (Fanconi) aplastic anemia. Blood. 80:1992;382-389.
51. Wodnar-Filipowicz A., Tichelli A., Zsebo K.M., Speck B., Nissen C. Stem cell factor stimulates the in vitro growth of bone marrow cells from aplastic anemia patients. Blood. 79:1992;3196-3202.
52. Amano Y., Koike K., Nakahata T. Stem cell factor enhances the growth of primitive erythroid progenitors to a greater exent than interleukin 3 in patients with aplastic anaemia. Br J Haematol. 85:1993;663-669.
53. Wodnar-Filipowicz A., Yancik S., Moser Y.et al. Levels of soluble stem cell factor in serum of patients with aplastic anemia. Blood. 81:1993;3259-3264.
54. Nimer S.D., Leung D.H.Y., Wolin M.J., Golde D.W. Serum stem cell factor levels in patients with aplastic anemia. Int J Hematol. 60:1994;185-189.
55. Kojima S., Matsuyama T., Kodera Y. Plasma levels and production of soluble stem cell factor by marrow stromal cells in patients with aplastic anemia. Br J Haematol. 99:1997;440-446.
56. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood. 67:1986;257-267.
57. Gasson J.C. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood. 77:1991;1131-1145.
58. Vadhan-Raj S., Buescher S., Broxmeyer H.E.et al. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. New Engl J Med. 139:1988;1628-1634.
59. Champlin R.E., Nimer S.D., Ireland P., Otte D.H., Golde D.W. Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage colony-stimulating factor. Blood. 73:1989;694-699.
60. Schrezenmeier H., Raghavachar A., Heimpel H. Granulocyte-macrophage colony-stimulating factor in the sera of patients with aplastic anemia. Clin Invest. 71:1993;102-108.
61. Nimer S.D., Golde D.W., Kwan K., Lee K., Clark S., Champlin R. In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of antithymocyte globulin. Blood. 78:1991;163-168.
62. Kawano Y., Takaue Y., Hirao A.et al. Production of interleukin 3 and granulocyte-macrophage colony-stimulating factor from stimulated blood mononuclear cells in patients with aplastic anemia. Exp Hematol. 20:1992;1125-1128.
63. Kojima S., Matsuyama T., Kodera Y. In vitro granulocyte-macrophage colony-stimulating factor production by peripheral blood mononuclear cells in aplastic anemia. Acta Haematol. 91:1992;175-180.
64. Kawano Y., Nissen C., Gratwohl A., Speck B. Immunostimulatory effects of different antilymphocyte globulin preparations: a possible clue to their clinical effect. Br J Haematol. 68:1988;115-119.
65. Abe T., Matsuoka H., Kojima S.et al. Correlation of response of aplastic anemia to antilymphocyte globulin with in vitro lymphocyte stimulatory effect: predictive value of in vitro test for clinical response. Blood. 77:1991;2225-2230.
66. Lyman S.D., James L., Vanden B.T.et al. Molecular cloning of a ligand for the flt-3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell. 75:1993;1157-1167.
67. Hannum C., Culpepper J., Campbell D.et al. Ligand for flt-3/flk-2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature. 368:1994;643-648.
68. Matthews W., Jordan C.T., Wiegand G.W., Pardoll D., Lemischka I.R. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell. 65:1991;1143-1152.
69. Small D., Levenstein M., Kim E.et al. STK-1, the human homolog of flk-2/flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA. 91:1994;459-463.
70. Lyman S.D., James L., Escobar S.et al. Identification of soluble and membrane-bound isoforms of the murine flt-3 ligand generated by alternative splicing of mRNAs. Oncogene. 10:1995;149-157.
71. Hudak S., Hunte B., Culpepper J.et al. Flt-3/flk-2 ligand promotes the growth of murine stem cells and the expansion of colony-forming cells and spleen colony-forming units. Blood. 85:1995;2747-2755.
72. Muench M.O., Roncarolo M.G., Menon S.et al. Flk-2/flt-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver. Blood. 85:1995;963-972.
73. Rusten L.S., Lyman S.D., Veiby O.P., Jacobsen S.E.W. The flt-3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cell in vitro. Blood. 87:1996;1317-1325.
74. Scope J., Daly S., Ball S.E., McGuckin C.P., Gordon-Smith E.C., Gibson F.M. The effect of human flt-3 ligand on committed progenitor cell production from normal, aplastic anaemia and Diamond-Blackfan anaemia bone marrow. Br J Haematol. 91:1995;544-550.
75. Lyman S.D., Seaberg M., Hanna R.et al. Flt-3 ligand plasma/serum levels are low in normal individuals and are highly elevated in patients with Fanconi anemia and acquired aplastic anemias. Blood. 86:1995;4091-4096.
76. Wodnar-Filipowicz A., Lyman S.D., Gratwohl A., Tichelli A., Speck B., Nissen C. Flt-3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood. 88:1996;4493-4499.
77. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood. 77:1991;1627-1652.
78. Walsh C.E., Liu S.M., Anderson S.M., Rossio J.L., Nienhuis A.W., Young N.S. A trial of recombinant human interleukin-1 in patients with severe refractory aplastic anemia. Br J Haematol. 80:1992;106-110.
79. Gascon P., Scala G. Decreased interleukin-1 production in aplastic anemia. Am J Med. 85:1988;668-674.
80. Nakao S., Matsushima K., Young N. Decreased interleukin-1 production in aplastic anaemia. Br J Haematol. 71:1989;431-436.
81. Andreesen R., Brugger W., Thomssen C., Rehm A., Speck B., Lohr G. Defective monocyte-to-macrophage maturation in patients with aplastic anemia. Blood. 74:1989;2150-2156.
82. Knospe W.H., Crosby W.H. Aplastic anemia: a disorder of the bone marrow sinusoidal microcirculation rather than stem cell failure. Lancet. 1:1971;20-22.
83. Ershler W.B., Ross J., Finlay J.L., Shahidi N.T. Bone marrow microenvironmental defect in congenital hypoplastic anemia. New Engl J Med. 302:1980;1322-1327.
84. Holmberg L.A., Seidel K., Leisenring W., Torok-Storb B. Aplastic anemia: analysis of stroma cell function in long-term marrow cultures. Blood. 84:1994;3685-3690.
85. Krieger-Slanicka M., Nissen C., Wodnar-Filipowicz A. Stem cell factor in aplastic anaemia: in vitro expression in bone marrow stroma and fibroblast cultures. Eur J Haematol. 54:1995;262-269.
86. Kojima S., Matsuyama T., Kodera Y. Hematopoietic growth factors released by marrow stromal cells from patients with aplastic anemia. Blood. 79:1992;2256-2261.
87. Hotta T., Kato T., Maeda H., Yamao H., Yamada H., Saito H. Functional changes in marrow stromal cells in aplastic anemia. Acta Haematol. 74:1985;65-69.
88. Marsh J.C.W., Chang J., Testa N.G., Hows J.M., Dexter T.M. The hematopoietic defect in aplastic anemia assessed by long-term marrow culture. Blood. 76:1990;1748-1757.
89. Tani K., Ozawa K., Ogura H.et al. The production of granulocyte colony stimulating factor and interleukin-6 by human bone marrow stromal cells in aplastic anemia. Tohoku J Exp Med. 169:1993;325-332.
90. Gibson F.M., Scopes J., Daly S., Ball S., Gordon-Smith E.C. Haemopoietic growth factor production by normal and aplastic anaemia stroma in long-term bone marrow culture. Br J Haematol. 91:1995;551-561.
91. Hirayama Y., Kohgo Y., Matsunaga T., Ohi S., Sakamaki S., Niitsu Y. Cytokine mRNA expression of bone marrow stromal cells from patients with aplastic anaemia and myelodysplastic syndrome. Br J Haematol. 85:1993;676-683.
92. Stark R., Andre C., Thierry D., Cherel M., Galibert F., Gluckman E. The expression of cytokine and cytokine receptor genes in long-term bone marrow culture in congenital and acquired marrow hypoplasias. Br J Haematol. 83:1993;560-566.